Sean Maduck
2017
In 2017, Sean Maduck earned a total compensation of $2.8M as Senior Vice President, Commercial at Corcept Therapeutics.
Compensation breakdown
| Bonus | $320,000 |
|---|---|
| Option Awards | $2,036,818 |
| Salary | $397,917 |
| Total | $2,754,735 |
Maduck received $2M in option awards, accounting for 74% of the total pay in 2017.
Maduck also received $320K in bonus and $397.9K in salary.
Rankings
In 2017, Sean Maduck's compensation ranked 3,982nd out of 14,666 executives tracked by ExecPay. In other words, Maduck earned more than 72.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,982 out of 14,666 | 73rd |
Division Manufacturing | 1,395 out of 5,772 | 76th |
Major group Chemicals And Allied Products | 402 out of 2,075 | 81st |
Industry group Drugs | 311 out of 1,731 | 82nd |
Industry Pharmaceutical Preparations | 248 out of 1,333 | 81st |
Source: SEC filing on April 24, 2018.
Maduck's colleagues
We found four more compensation records of executives who worked with Sean Maduck at Corcept Therapeutics in 2017.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019